Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials
出版年份 2021 全文链接
标题
Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials
作者
关键词
-
出版物
ADVANCES IN THERAPY
Volume 38, Issue 3, Pages 1614-1626
出版商
Springer Science and Business Media LLC
发表日期
2021-02-05
DOI
10.1007/s12325-021-01632-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
- (2019) Simona Sacco et al. JOURNAL OF HEADACHE AND PAIN
- A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody
- (2019) William Kielbasa et al. CEPHALALGIA
- Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
- (2019) Virginia L. Stauffer et al. HEADACHE
- Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
- (2019) Holland C. Detke et al. HEADACHE
- Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial
- (2018) Vladimir Skljarevski et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Calcitonin-gene-related peptide pathway mAbs and migraine prevention
- (2018) Koen Paemeleire et al. CURRENT OPINION IN NEUROLOGY
- The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
- (2018) Bianca Raffaelli et al. Neurotherapeutics
- Evaluation of Galcanezumab for the Prevention of Episodic Migraine
- (2018) Virginia L. Stauffer et al. JAMA Neurology
- Preventive effects of galcanezumab in adult patients with episodic or chronic migraine are persistent: data from the phase 3, randomized, double-blind, placebo-controlled EVOLVE-1, EVOLVE-2, and REGAIN studies
- (2018) Stefanie Förderreuther et al. JOURNAL OF HEADACHE AND PAIN
- Galcanezumab in chronic migraine
- (2018) Holland C. Detke et al. NEUROLOGY
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Understanding migraine: Potential role of neurogenic inflammation
- (2016) Rakesh Malhotra Annals of Indian Academy of Neurology
- Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
- (2016) Zsolt Hepp et al. CEPHALALGIA
- Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention
- (2015) Richard B. Lipton et al. HEADACHE
- Acute Migraine Treatment in Adults
- (2015) Werner J. Becker HEADACHE
- Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
- (2014) Stephen D Silberstein et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Is 6 months of migraine prophylaxis adequate?
- (2013) Sanjeev K Bhoi et al. NEUROLOGICAL RESEARCH
- Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1
- (2012) S.D. Silberstein et al. NEUROLOGY
- Publication committees in clinical trials in headache
- (2011) Peer Carsten Tfelt-Hansen et al. CEPHALALGIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More